Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 03/04/2019
Entire Document
 


Case 18-10518-KG     Doc 958     Filed 02/28/19     Page 7 of 11

 

In re: Orexigen Therapeutics, Inc.

   Case No. 18-10518 (KG)

Debtor

   Reporting Period: January 1, 2019 - January 31, 2019

 

MOR - 1c

Schedule of Professional Fees and Expenses Paid

For the Period: January 1, 2019 - January 31, 2019

(Unaudited)

 

                                Month Ended 1/31/19                      Cumulative Since Filing      
 Payee   Category   Payor       Date   Period Covered   Fees     Expenses     Fees     Expenses  

 

 

Retained Professionals

               

Hogan Lovells US LLP

 

Debtor Counsel

 

Orexigen Therapeutics, Inc.            

  1/21/2019 3/12/2018 - 11/30/2018   $ 27,016     $ 1,079     $ 2,402,913     $ 33,439  

Morris, Nichols, Arsht & Tunnell LLP

 

Debtor Local Counsel

 

Orexigen Therapeutics, Inc.

  1/21/2019 3/12/2018 -11/30/2018     6,344       160       774,670       22,093  

Ernst & Young, LLP

 

Debtor Financial Advisor

 

Orexigen Therapeutics, Inc.

  1/21/2019 3/12/2018 -11/30/2018     198,421       6,874       2,101,655       202,314  

Perella Weinberg Partners

 

Debtor Investment Banker

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 7/27/2018     -       -       3,411,713       3,600  

Irell & Manella LLP

 

Committee Counsel

 

Orexigen Therapeutics, Inc.

  1/24/2019 3/12/2018 -11/30/2018     56,840       1,030       716,570       14,874  

Berkeley Research Group LLC

 

Committee Financial Advisor

 

Orexigen Therapeutics, Inc.

  1/21/2019 3/27/2018 -11/30/2018     8,179       -       248,537       2,869  

Elliott Greenleaf, P.C.

 

Committee Local Counsel

 

Orexigen Therapeutics, Inc.

  1/24/2019 3/27/2018 -11/30/2018     6,584       17       103,449       598  

Kurtzman Carson Consultants LLC

 

Claims Agent

 

Orexigen Therapeutics, Inc.

  1/21/2019 3/12/2018 -11/30/2018     18,462       -       453,282       167,920  

Landis Rath & Cobb LLP

 

Debtor Conflict Counsel

 

Orexigen Therapeutics, Inc.

  1/21/2019 6/14/2018 -11/30/2018     3,316       7       182,187       2,191  

Other Restructuring Professionals

               

Wilmington Trust, National Association

 

DIP Administrative Agent

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 7/31/2018   $ -     $ -     $ 51,600     $ -  

Arnold & Porter Kaye Scholer LLP

 

DIP Administrative Agent Counsel

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 7/27/2018     -       -       131,889       1,034  

Quinn Emanuel Urquhart & Sullivan, LLP    

 

DIP Lenders Counsel

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 10/31/2018     -       -       1,023,973       19,636  

Brown Rudnick LLP

 

DIP Lender Counsel

 

Orexigen Therapeutics, Inc.

  2/15/2018 - 5/31/2018     -       -       147,048       1,497  

Whiteford Taylor Preston

 

DIP Lenders Local Counsel

 

Orexigen Therapeutics, Inc.

  1/24/2019 3/12/2018 -12/31/2018     13,958       -       237,215       2,141  

U.S. Bank, N.A.

 

Indenture Trustee

 

Orexigen Therapeutics, Inc.

  3/1/2018 - 9/30/2018     -       -       820,605       3,040  

Duane Morris

 

DIP Administrative Agent Secondary Counsel    

 

Orexigen Therapeutics, Inc.

  4/10/2018 - 7/27/2018     -       -       17,609       -  

 

 

Total

          $ 339,121     $ 9,167     $ 12,824,915     $ 477,247